Literature DB >> 3102675

Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3).

M L Plunkett, M E Sanders, P Selvaraj, M L Dustin, T A Springer.   

Abstract

CD2, also known as LFA-2, T11, and the E rosette receptor, is a T lymphocyte surface protein functionally important in adhesion to target cells and T cell triggering. LFA-3 is a widely distributed cell surface protein that functions in adhesion on target cells. We find that LFA-3 is expressed on human E, and that CD2 is a receptor for LFA-3 that mediates T cell adhesion to human E. Pretreatment of T lymphocytes with CD2 mAb or of E with LFA-3 mAb inhibits rosetting. Purified CD2 molecules bind to human E and inhibit rosetting. 125I-CD2 binding to E is inhibited by LFA-3 mAb; reciprocally, binding of LFA-3 mAb to human E is inhibited by pretreatment with purified CD2. Higher concentrations of CD2 aggregate human E; aggregation is inhibited by mAb to LFA-3.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3102675      PMCID: PMC2188280          DOI: 10.1084/jem.165.3.664

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  Lymphocyte: erythrocyte (L.E.) rosettes as indicators of the heterogeneity of lymphocytes in a variety of mammalian species.

Authors:  C M Braganza; G Stathopoulos; A J Davies; E V Elliott; R S Kerbel; M Papamichail; E J Holborow
Journal:  Cell       Date:  1975-02       Impact factor: 41.582

2.  Thymocyte binding to human thymic epithelial cells is inhibited by monoclonal antibodies to CD-2 and LFA-3 antigens.

Authors:  L W Vollger; D T Tuck; T A Springer; B F Haynes; K H Singer
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

3.  Functional consequences of sheep red blood cell rosetting for human T cells: gain of reactivity to mitogenic factors.

Authors:  E L Larsson; J Andersson; A Coutinho
Journal:  Eur J Immunol       Date:  1978-10       Impact factor: 5.532

4.  Letter: Auto-rosette formation by human thymocytes and lymphocytes.

Authors:  G Sandilands; K Gray; A Cooney; J D Browning; J R Anderson
Journal:  Lancet       Date:  1974-01-05       Impact factor: 79.321

5.  Binding of sheep red blood cells to a large population of human lymphocytes.

Authors:  W H Lay; N F Mendes; C Bianco; V Nussenzweig
Journal:  Nature       Date:  1971-04-23       Impact factor: 49.962

6.  Detergent solubilization, purification, and separation of specificities of HLA antigens from a cultured human lymphoblastoid line, RPMI 4265.

Authors:  T A Springer; D L Mann; A L DeFranco; J L Strominger
Journal:  J Biol Chem       Date:  1977-07-10       Impact factor: 5.157

7.  Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction.

Authors:  R Palacios; L Llorente; D Alarcón-Segovia; A Ruíz-Arguelles; E Díaz-Jouanen
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

8.  Self recognition by autologous mixed lymphocyte reaction-primed cells.

Authors:  K Tomonari; A Wakisaka; M Aizawa
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

9.  Rosetting of human red blood cells to thymocytes and thymus-derived cells.

Authors:  G Baxley; G B Bishop; A G Cooper; H H Wortis
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  24 in total

1.  Functional glycan-free adhesion domain of human cell surface receptor CD58: design, production and NMR studies.

Authors:  Z Y Sun; V Dötsch; M Kim; J Li; E L Reinherz; G Wagner
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

2.  Effect of lengthening lymphocyte function-associated antigen 3 on adhesion to CD2.

Authors:  P Y Chan; T A Springer
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

Review 3.  Antigen presenting cells.

Authors:  D L Hamilos
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

4.  Functional properties of human lamina propria T lymphocytes assessed with mitogenic monoclonal antibodies.

Authors:  L Qiao; G Schürmann; M Betzler; S C Meuer
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

5.  Red blood cells carry out T cell growth and survival bioactivities that are sensitive to cyclosporine A.

Authors:  Ricardo F Antunes; Cláudia Brandão; Gonçalo Carvalho; Cristina Girão; Fernando A Arosa
Journal:  Cell Mol Life Sci       Date:  2009-10       Impact factor: 9.261

6.  Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells.

Authors:  H A Stafford; M L Tykocinski; D M Lublin; V M Holers; W F Rosse; J P Atkinson; M E Medof
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

7.  Expression of the T-cell surface molecule CD2 and an epitope-loss CD2 mutant to define the role of lymphocyte function-associated antigen 3 (LFA-3) in T-cell activation.

Authors:  B E Bierer; A Peterson; J Barbosa; B Seed; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

8.  Monoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells.

Authors:  H Yagita; T Nakamura; H Karasuyama; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

9.  Direct evidence for a receptor-ligand interaction between the T-cell surface antigen CD2 and lymphocyte-function-associated antigen 3.

Authors:  Y Takai; M L Reed; S J Burakoff; S H Herrmann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

Review 10.  Signal initiation in biological systems: the properties and detection of transient extracellular protein interactions.

Authors:  Gavin J Wright
Journal:  Mol Biosyst       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.